The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics of the anticoagulant Eliquis (apixaban).

The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics of the anticoagulant Eliquis (apixaban).

Feature | Antiplatelet and Anticoagulation Therapies | December 27, 2019

December 27, 2019 — The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics...

The Wyss Translational Center in Zurich, Switzerland has developed the LifeMatrix platform to engineer tissues that can be implanted in patients and will grow with them. This technology is being developed for heart valves in younger patients to eliminate the need for repeat surgeries to implant larger prosthetic heart valves as the patient grows.

The Wyss Translational Center in Zurich, Switzerland has developed the LifeMatrix platform to engineer tissues that can be implanted in patients and will grow with them. This technology is being developed for heart valves in younger patients to eliminate the need for repeat surgeries to implant larger prosthetic heart valves as the patient grows.

 

News | Heart Valve Technology | December 26, 2019

While transcatheter heart valve replacement and repair devices are growing in popularity due to their delivery and...

Peter Weiss, M.D., explains a Stereotaxis robotically navigated cardiac ablation procedure at Banner University Medicine Heart Institute.

Peter Weiss, M.D., explains a Stereotaxis robotically navigated cardiac ablation procedure at Banner University Medicine Heart Institute.

Feature | EP Lab | December 23, 2019 | J. Peter Weiss, M.D., MSc

Robotic technology, which helps...

The high cost of EP mapping and ablation catheters consumes about 60 percent of CMS reimbursement for atrial fibrillation catheter ablation procedures. This has led some hospitals to start reprocessing the catheters to cut costs.

The high cost of EP mapping and ablation catheters consumes about 60 percent of CMS reimbursement for atrial fibrillation catheter ablation procedures. This has led some hospitals to start reprocessing the catheters to cut costs. Photo by Dave Fornell.

Blog | Cardiovascular Business | December 23, 2019

With all eyes on rising healthcare costs, reprocessing of single-use devices has become an increasingly important...

Top Cardiology New in 2019 From the European Society of Cardioloigy (ESC)
News | Cardiovascular Clinical Studies | December 23, 2019

Environmental and lifestyle issues were popular this year, with pick up from both...

Videos | Cardiovascular Ultrasound | December 20, 2019

This is the LVivo auto cardiac ejection fraction (EF) app that uses...

Developed by Eko, a digital health company applying artificial intelligence (AI) in heart disease, the algorithm analyzes 15 seconds of ECG data collected from the Eko Duo digital stethoscope. The data can be collected during a physical exam and helps identify reduced left ventricular ejection fraction (LVEF), a measure commonly used to diagnose patients with heart failure.
News | Cardiac Diagnostics | December 19, 2019

December 19, 2019 — The U.S. Food and Drug Administration (FDA) has granted breakthrough status for a novel ECG-...

Videos | RSNA | December 18, 2019

DAIC Editor Dave Fornell and Imaging Technology News (ITN) Consulting Editor Greg Freiherr offer a post-game report...

heart disease image
News | Cardiac Diagnostics | December 18, 2019

December 18, 2019 — In their latest report, “...

 Revivant TC
News | Heart Failure | December 18, 2019

December 18, 2019 — BioVentrix, Inc., developer of the first less...

News | Cath Lab | December 18, 2019

December 18, 2019 — Cook Medical initiated a recall of its CrossCath Support Catheters in November, which the U.S....

Overlay Init